Skip to Content

KU 180 (Pantoprazole sodium delayed release 20 mg)

Pill imprint KU 180 has been identified as Pantoprazole sodium delayed release 20 mg.

Pantoprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; dumping syndrome; zollinger-ellison syndrome (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Pantoprazole sodium delayed release 20 mg KU 180
Pantoprazole sodium delayed release 20 mg KU 180
Discount Card Promo
Pantoprazole sodium delayed release
KU 180
20 mg
Elliptical / Oval
Prescription only
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Kremers Urban
National Drug Code (NDC):
Inactive Ingredients:
ferrosoferric oxide
glyceryl dibehenate
isopropyl alcohol
lactose monohydrate
propylene glycol
magnesium silicate
titanium dioxide
triethyl citrate
methacrylic acid - methyl methacrylate copolymer (1:1)
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0643 Amerisource Health Services

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.